Cargando…
Dysfunctional oxidative phosphorylation makes malignant melanoma cells addicted to glycolysis driven by the (V600E)BRAF oncogene
Oncogene addiction describes how cancer cells exhibit dependence on single oncogenes to escape apoptosis and senescence. While oncogene addiction constitutes the basis for new cancer treatment strategies targeting individual kinases and pathways activated by oncogenic mutations, the biochemical basi...
Autores principales: | Hall, Arnaldur, Meyle, Kathrine Damm, Lange, Marina Krarup, Klima, Martin, Sanderhoff, May, Dahl, Christina, Abildgaard, Cecilie, Thorup, Katrine, Moghimi, Seyed Moein, Jensen, Per Bo, Bartek, Jiri, Guldberg, Per, Christensen, Claus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720606/ https://www.ncbi.nlm.nih.gov/pubmed/23603840 |
Ejemplares similares
-
Bioenergetic modulation with dichloroacetate reduces the growth of melanoma cells and potentiates their response to BRAF(V600E) inhibition
por: Abildgaard, Cecilie, et al.
Publicado: (2014) -
Inhibition of retinoic acid receptor β signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells
por: Abildgaard, Cecilie, et al.
Publicado: (2017) -
Differential Inhibition of Ex-Vivo Tumor Kinase Activity by Vemurafenib in BRAF(V600E) and BRAF Wild-Type Metastatic Malignant Melanoma
por: Tahiri, Andliena, et al.
Publicado: (2013) -
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma
por: Abildgaard, Cecilie, et al.
Publicado: (2021) -
BRAF(V600E) protein expression and outcome from BRAF inhibitor treatment in BRAF(V600E) metastatic melanoma
por: Wilmott, J S, et al.
Publicado: (2013)